Eli Lilly and Co. / GlaxoSmithKline / Merck / Schering Plough Eli Lilly & Co. / AstraZeneca / Glaxosmithkline plc / /
Continent
America / Europe / /
Country
Italy / United States / United Kingdom / China / /
Currency
GBP / USD / /
Event
Judicial Event / FDA Phase / /
Facility
National Institute of Mental Health / Verona facility / Institute of Medicine / ADAPTED BY PERMISSION OF THE INSTITUTE OF MEDICINE / Harlow facility / Harvard University / /
IndustryTerm
pharmaceutical industry / treatment of mental illness / Therapeutics for Rare and Neglected Diseases / executive publisher / /
National Institute of Health / Harvard University / Food and Drug Administration / Institute of Medicine / CENTER FOR THE STUDY OF DRUG DEVELOPMENT / Tufts Center for the Study / Congress / Harvard NeuroDiscovery Center / TUFTS CENTER FOR THE STUDY OF DRUG / National Institute of Mental Health / /
Person
William Potter / Given / Steven Hyman / Greg Miller / Adrian Ivinson / Steven Paul / Thomas Insel / Kenneth Kaitin / Andrew Witty / Alan Leshner / RATTI FOUND / /
Position
psychiatrist / director of the Tufts center / model of drug development / Chief Executive / vice president for neuroscience / author / senior vice president and head / model / director / executive vice president for science and technology / chair / executive / /
NEWSFOCUS Is Pharma Running Out of Brainy Ideas? These cutbacks by two of the top players in drug development for disorders of the